Wright Robin 4
4 · Barinthus Biotherapeutics plc. · Filed May 14, 2024
Insider Transaction Report
Form 4
Wright Robin
Director
Transactions
- Award
Share Option (Right to Buy)
2024-05-10+19,516→ 19,516 totalExercise: $2.34Exp: 2034-05-10→ Ordinary Shares (19,516 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.